Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IDNA vs. LOGSX: which is better?

Bottom line

IDNA vs LOGSX: the short answer

IDNA (iShares Genomics Immunology and Healthcare ETF) and LOGSX (Live Oak Health Sciences Fund) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.

But IDNA is far broader, holding 61 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.

IDNA is cheaper at 0.47% vs 1.04% — a difference of $57 a year per $10,000 invested.

Over five years, LOGSX returned +8.1% a year vs −4.8% for IDNA (reporting dates differ).

Updated Nov 19, 2026

IDNA vs LOGSX side by side

IDNALOGSX
TypeETFMutual fund
Fund familyiSharesOak Associates
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.47%1.04%
Annual cost per $10k$47$104
10-yr cost on $10k (prospectus)$591$1,271
Max front loadNone—
12b-1 fee0%—
1-yr return−1.0%+19.6%
5-yr return (annualized)−4.8%+8.1%
10-yr return (annualized)—+7.3%
Best quarter+41.9%+13.4%
Worst quarter−21.5%−13.1%
Net assets (fund)$190.9M$56.1M
Number of holdings6128
Portfolio turnover49%24%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIDNALOGSXDifference
2024−1.0%+0.2%−1.2%
2023−7.8%+1.2%−9.0%
2022−42.1%+3.7%−45.8%
2021−4.0%+17.5%−21.5%
2020+54.5%+6.0%+48.5%

Source: Fund prospectus bar charts

Holdings overlap

5 of IDNA's top 25 holdings also appear in LOGSX's top 25.

Shared top holdings
HoldingIDNALOGSX
Regeneron Pharmaceuticals, Inc.4.35%4.43%
Incyte Corporation4.23%3.30%
Merck & Co., Inc.3.91%3.16%
Vertex Pharmaceuticals Incorporated3.87%3.26%
Exelixis, Inc.3.65%4.95%

Source: SEC Form N-PORT

IDNA top 10

  1. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
  2. Bayer Aktiengesellschaft — 4.81%
  3. Twist Bioscience Corp — 4.79%
  4. Revolution Medicines, Inc. — 4.55%
  5. Regeneron Pharmaceuticals, Inc. — 4.35%
  6. Genmab A/s — 4.23%
  7. Incyte Corporation — 4.23%
  8. Moderna, Inc. — 4.19%
  9. Takeda Pharmaceutical Company Limited — 4.05%
  10. Merck & Co., Inc. — 3.91%

LOGSX top 10

  1. N/a — 6.91%
  2. Cardinal Health Inc — 5.86%
  3. Jazz Pharmaceuticals Plc — 5.77%
  4. United Therapeutics Corp — 5.11%
  5. Exelixis Inc — 4.95%
  6. Amgen Inc — 4.86%
  7. Lantheus Holdings Inc — 4.68%
  8. Novartis Ag — 4.67%
  9. Mckesson Corp — 4.53%
  10. Cencora Inc — 4.46%

FAQ

What is the difference between IDNA and LOGSX?
IDNA (iShares Genomics Immunology and Healthcare ETF) and LOGSX (Live Oak Health Sciences Fund) are quite different portfolios: only about 18% of their top holdings (by weight) are shared. But IDNA is far broader, holding 61 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.
Which is cheaper, IDNA or LOGSX?
IDNA has the lower expense ratio (0.47%).
Should I own both IDNA and LOGSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.